News
Intel’s turnaround is at risk given political criticism of CEO Lip-Bu Tan. Can he and Trump work together to resurrect U.S.
One big question around the long-drawn-out merger of Paramount and Skydance was what its new CEO, David Ellison, would do ...
Listening without prejudice to people’s worst financial decisions may be helpful in avoiding the same mistakes.
A tame CPI release on Tuesday could catalyze a shift in market leadership toward small-caps and lower-quality stocks. That’s ...
Cannabis stocks rallied on Monday after a report by The Wall Street Journal that President Donald Trump may consider lowering ...
Two of the three major U.S. indexes were trading above their last record closes on Monday morning as investors monitored ...
The Bank of Canada conducted the survey of about 30 market participants from late June to early July. Since then, Canada and the U.S. have failed to come to an agreement to resolve the current tariff ...
Shares of Telos surged after the company reported better revenue trends than Wall Street had been expecting and said it had started repurchasing stock again. The stock was up 47% at $3.50 in early ...
Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].
Ballard Power Systems shares fell Monday after reporting lower-than-expected revenue in the second quarter as revenue from hydrogen fuel-cell systems for buses decline. Shares fell 2.4% to 2.44 ...
Humacyte shares were 26% lower, at $1.84, after the company reported a second-quarter loss that was wider than analysts' expectations. The biotechnology company said it had a quarterly loss of $37.7 ...
Bullish on Monday said it now plans to sell 30 million shares at between $32 and $33 apiece in the IPO, up from prior plans to offer 20.3 million shares at between $28 and $31 each.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results